Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

2018 Pan Pacific Lymphoma Conference
J

Novel Cell Pathway Targeted Agents for DLBCL: Determining Cell-of-Orgin

By 2018 Pan Pacific Lymphoma Conference FEATURING Julie M. Vose
By 2018 Pan Pacific Lymphoma Conference FEATURING Julie M. Vose
129 views
August 15, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey
Novel Therapies in Lymphoma
13:17

Novel Cell Pathway Targeted Agents for DLBCL: Determining Cell-of-Or…

2018 Pan Pacific Lymphoma Conference

J. Vose

129 views
25:30

How do we Incoporate PET-CT into Standard of Lymphoma Care and Resea…

2018 Pan Pacific Lymphoma Conference

B. Cheson

45 views
09:28

Novel Cell Pathway Targeted Agents for Relapsed DLBCL

2018 Pan Pacific Lymphoma Conference

J. Vose

420 views
22:02

New Antibody-Drug Conjugates

2018 Pan Pacific Lymphoma Conference

B. Kahl

527 views
17:33

Novel-Novel Drug Combinations in B-cell Malignancies

2018 Pan Pacific Lymphoma Conference

K. Dunleavy

255 views